Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2A
基于 CDK4/CDKN2A mRNA 表达的 CDK4/6 抑制剂 palbociclib 治疗晚期肉瘤的 II 期临床试验
期刊:Signal Transduction and Targeted Therapy
影响因子:40.8
doi:10.1038/s41392-023-01661-8
Javier Martin-Broto ,Jeronimo Martinez-Garcia ,David S Moura ,Andres Redondo ,Antonio Gutierrez ,Antonio Lopez-Pousa ,Javier Martinez-Trufero ,Isabel Sevilla ,Roberto Diaz-Beveridge ,Maria Pilar Solis-Hernandez ,Amancio Carnero ,Marco Perez ,David Marcilla ,Jesus Garcia-Foncillas ,Pablo Romero ,Javier Fernandez-Jara ,Daniel Lopez-Lopez ,Ivan Arribas ,Nadia Hindi